Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: The PREMIUM Study
- 1 November 2012
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiology
- Vol. 60 (5) , 389-394
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophagesBiochemical and Biophysical Research Communications, 2008
- A 52-Week, Randomized, Open-Label, Parallel-Group Comparison of the Tolerability and Effects of Pitavastatin and Atorvastatin on High-Density Lipoprotein Cholesterol Levels and Glucose Metabolism in Japanese Patients with Elevated Levels of Low-Density Lipoprotein Cholesterol and Glucose IntoleranceClinical Therapeutics, 2008
- Pitavastatin: efficacy and safety in intensive lipid loweringExpert Opinion on Pharmacotherapy, 2007
- Effects of Pitavastatin on Adiponectin in Patients with HyperlipidemiaPathophysiology of Haemostasis and Thrombosis, 2007
- The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: A pilot studyClinical Therapeutics, 2006
- Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese MenArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- The Effect of Statins on mRNA Levels of Genes Related to Inflammation, Coagulation, and Vascular Constriction in HUVEC.Journal of Atherosclerosis and Thrombosis, 2002
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989